2022年12月最新中科院JCR期刊分区表数据(升级版)已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。 ![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | BLOOD BLOOD LetPub评分 9.8
51人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.6 | |||||||||||||||||||||||||||||
期刊ISSN | 0006-4971 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||
E-ISSN | 1528-0020 | |||||||||||||||||||||||||||||
2021-2022最新影响因子 (数据来源于搜索引擎) | 25.476 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||
2021-2022自引率 | 3.10%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
h-index | 426 | |||||||||||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||||||||||
期刊简介 | Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal. | |||||||||||||||||||||||||||||
期刊官方网站 | http://bloodjournal.hematologylibrary.org/ | |||||||||||||||||||||||||||||
期刊投稿网址 | http://submit.bloodjournal.org/ | |||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BLOOD的语言要求,还能让BLOOD编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BLOOD编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||
通讯方式 | AMER SOC HEMATOLOGY, 1900 M STREET. NW SUITE 200, WASHINGTON, USA, DC, 20036 | |||||||||||||||||||||||||||||
出版商 | American Society of Hematology | |||||||||||||||||||||||||||||
涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||
出版周期 | Semimonthly | |||||||||||||||||||||||||||||
出版年份 | 1946 | |||||||||||||||||||||||||||||
年文章数 | 501点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
Gold OA文章占比 | 1.88% | |||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 91.82% | |||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2021-2022年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2021年01月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2022年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月基础版) |
| |||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月升级版) |
| |||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年12月旧的升级版) |
| |||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0006-4971%5BISSN%5D | |||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均1.0个月 | |||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较难 | |||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在BLOOD顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Author: Kusumoto S1, Arcaini L2,3, Hong X4, Jin J5, Kim WS6, Kwong YL7, Peters MG8, Tanaka Y9, Zelenetz AD10,11, Kuriki H12, Fingerle-Rowson G13, Nielsen T13, Ueda E12, Piper-Lepoutre H13, Sellam G13, Tobinai K14. Journal: Blood. 2019 Jan 10;133(2):137-146. doi: 10.1182/blood-2018-04-848044. Epub 2018 Oct 19. PubMed DOI |
2. | The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses. Author: Zhao Z1, Wu Y1,2, Zhou J1,2, Chen F1, Yang A1, Essex DW2. Journal: Blood. 2019 Jan 17;133(3):246-251. doi: 10.1182/blood-2018-04-844480. Epub 2018 Nov 13. PubMed DOI |
3. | BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis. Author: Yu S1, Jiang T1, Jia D1, Han Y1, Liu F1, Huang Y1, Qu Z1, Zhao Y2, Tu J1, Lv Y1, Li J1, Hu X1, Lu Z1, Han S1, Qin Y1, Liu X1, Xie S1, Wang QK1, Tang Z1, Luo D2,3, Liu M1. Journal: Blood. 2019 Feb 21;133(8):805-815. doi: 10.1182/blood-2018-09-876599. Epub 2018 Nov 27. PubMed DOI |
4. | Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics. Author: Qian M1,2,3, Xu H4, Perez-Andreu V1,5, Roberts KG6, Zhang H1,7, Yang W1, Zhang S4, Zhao X1, Smith C1, Devidas M8, Gastier-Foster JM9,10,11, Raetz E12, Larsen E13, Burchard EG14, Winick N15, Bowman WP16, Martin PL17, Borowitz M18, Wood B19, Antillon-Klussmann F20, Pui CH21,22, Mullighan CG6,22, Evans WE1,22, Hunger SP23,24, Relling MV1,22, Loh ML25,26, Yang JJ1,21,22. Journal: Blood. 2019 Feb 14;133(7):724-729. doi: 10.1182/blood-2018-07-862946. Epub 2018 Dec 3. PubMed DOI |
5. | Low-dose chidamide restores immune tolerance in ITP in mice and humans. Author: Zhao HY1,2, Ma YH1,3, Li DQ2, Sun T1, Li LZ1, Li P1,4, Liu XG1, Zhou H1, Hou Y1, Liu Y1, Han PP1, Zhao YJ1, Jing FM1, Peng J1,5, Hou M1,5,6,7. Journal: Blood. 2019 Feb 14;133(7):730-742. doi: 10.1182/blood-2018-05-847624. Epub 2018 Dec 14. PubMed DOI |
6. | Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. Author: Klanova M1,2,3, Sehn LH4, Bence-Bruckler I5, Cavallo F6, Jin J7, Martelli M8, Stewart D9, Vitolo U10, Zaja F11, Zhang Q12, Mattiello F13, Sellam G3, Punnoose EA14, Szafer-Glusman E14, Bolen CR15, Oestergaard MZ16, Fingerle-Rowson GR3, Nielsen T3, Trneny M1. Journal: Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7. PubMed DOI |
7. | Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia. Author: Xu S1,2,3,4,5,6, Luk K7, Yao Q1,2,3,4,5,8,9,10,11, Shen AH1,2,3,4,5, Zeng J1,2,3,4,5, Wu Y1,2,3,4,5,12,13,14, Luo HY15,16,17, Brendel C1,2,3,18, Pinello L4,8,9,10,11, Chui DHK15,16,17, Wolfe SA7,19, Bauer DE1,2,3,4,5. Journal: Blood. 2019 May 23;133(21):2255-2262. doi: 10.1182/blood-2019-01-895094. Epub 2019 Jan 31. PubMed DOI |
8. | Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma. Author: Zhuang J1,2, Shirazi F2, Singh RK2, Kuiatse I2, Wang H2, Lee HC2, Berkova Z2, Berger A3, Hyer M3, Chattopadhyay N3, Syed S3, Shi JQ3, Yu J3, Shinde V3, Tirrell S3, Jones RJ2, Wang Z2, Davis RE2, Orlowski RZ2,4. Journal: Blood. 2019 Apr 4;133(14):1572-1584. doi: 10.1182/blood-2018-06-859686. Epub 2019 Feb 8. PubMed DOI |
9. | Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease. Author: Zhang L1, Zhao AL1, Duan MH1, Li ZY2, Cao XX1, Feng J1, Zhou DB1, Zhong DR2,3, Fajgenbaum DC4, Li J1. Journal: Blood. 2019 Apr 18;133(16):1720-1728. doi: 10.1182/blood-2018-11-884577. Epub 2019 Feb 13. PubMed DOI |
10. | Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Author: Sanz MA1,2,3, Fenaux P4,5, Tallman MS6, Estey EH7, Löwenberg B8, Naoe T9, Lengfelder E10, Döhner H11, Burnett AK12, Chen SJ13, Mathews V14, Iland H15, Rego E16,17, Kantarjian H18, Adès L4,5, Avvisati G19, Montesinos P1,3, Platzbecker U20, Ravandi F18, Russell NH21, Lo-Coco F22. Journal: Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25. PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共7条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451